The clearance of apoptotic cells is important to maintain tissue homeostasis. The engulfment of apoptotic cells is performed by professional phagocytes, such as macrophages, and also by non-professional phagocytes, such as mesenchymal cells. Here, we show that vimentin, a cytoskeletal protein, functions as an engulfment receptor on neighboring phagocytes, which recognize O-linked β-Nacetylglucosamine (O-GlcNAc)-modified proteins from apoptotic cells as "eat me" ligands. Previously, we reported that vimentin possesses a GlcNAc-binding lectinlike property on cell surface. However, the physiological relevance of the surface localization and GlcNAc-binding property of vimentin remained unclear. In the present study, we observed that O-GlcNAc proteins from apoptotic cells interacted with the surface vimentin of neighboring phagocytes and that this interaction induced serine 71-phosphorylation and recruitment of vimentin to the cell surface of the neighboring phagocytes. Moreover, tetrameric vimentin that was disassembled by serine 71-phosphorylation possessed a GlcNAc-binding activity and was localized to the cell surface. We demonstrated our findings in vimentin-expressing common cell lines such as HeLa cells. Furthermore, during normal developmental processes, the phagocytic engulfment and clearance of apoptotic footplate cells in mouse embryos was mediated by the interaction of surface vimentin with O-GlcNAc proteins. Our results suggest a common mechanism for the clearance of apoptotic cells, through the interaction of surface vimentin with O-GlcNAc-modified proteins.
Introduction
The prompt clearance of dying cells, such as apoptotic and necrotic cells, is crucial for immune tolerance and tissue homeostasis. During the removal process, dying cells are engulfed by professional phagocytes, such as macrophages and dendritic cells. Studies with developing footplate cells remodeled to transform webbed regions into free interdigital spaces in macrophageless PU.1 null mouse embryos (Wood et al. 2000) have shown that, not only professional phagocytes, but also non-professional phagocytes, such as mesenchymal cells, engulf and clear dead cells. Moreover, macrophageless PU.1 null mice were able to repair skin wounds at the same speed as wild-type mice, by using stand-in phagocytic fibroblasts to engulf the dying cells (Martin et al. 2003) . Recently, several studies have shown that endothelial cells, mesenchymal cells, neural cells and fibroblasts (all of which function as non-professional "neighboring" phagocytes) can engulf apoptotic cells (Parnaik et al. 2000; Elliott and Ravichandran 2010) . Several molecules are involved in the recognition and removal of apoptotic cells. For example, the exposure of phosphatidylserine (PtdSer) on the outer leaflet of the apoptotic cell plasma membrane functions as an "eat me" marker, which mediates the interaction between apoptotic cells and phagocytes. Phagocytic recognition of PtdSer is mediated by PtdSer recognition receptors, including Bai1, Tim-4 and Stabilin-2, or by soluble bridging molecules that bind PtdSer on apoptotic cells and phagocytic receptors, e.g. MFG-E8/αvβ 3/5 and Gas6/MER (Elliott and Ravichandran 2010; Nagata et al. 2010) . Complement C1q and mannose-binding lectins also function as "eat me" receptors (Elliott and Ravichandran 2010) . It is assumed that professional and non-professional neighboring phagocytes clear apoptotic cells by different mechanisms, because they possess different signaling responses to these cells (Wood et al. 2000; Martin et al. 2003; Patel et al. 2010) . Moreover, during the clearance by non-professional phagocytes in PU.1 null mice, wound healing is performed in the absence of an inflammatory response (Martin et al. 2003) . The clearance of apoptotic cells by non-professional neighboring phagocytes is thought to play an important role in normal tissue homeostasis, because it can function without inflammation, and before professional phagocytes are recruited. However, the precise mechanism of clearance has not been fully elucidated.
In the present study, we show that vimentin (a cytoskeletal protein) and O-linked β-N-acetylglucosamine (O-GlcNAc)-modified proteins constitute novel candidates for an engulfment receptor and an "eat me" marker, respectively, in professional and also non-professional phagocytes. Vimentin is an intermediate filament protein found in mesenchymal cells and plays an important role in stabilizing the cytoplasmic architecture. Previously, O-GlcNAc-modified proteins were thought to exist only in the cytoplasm and nucleus; more than 500 intracellular proteins have been shown to be O-GlcNAcylated. These proteins are involved in almost all aspects of cellular metabolism (Hart et al. 2007) . Recently, we reported that vimentin possesses GlcNAc-binding lectin-like properties on the cell surface of various vimentin-expressing cells and interacts with O-GlcNAc-modified proteins via its rod II domain (Ise et al. 2010) . Moreover, vimentin interacts with and internalizes multivalent GlcNAcylated molecules, such as O-GlcNAc-modified proteins. It is commonly assumed that vimentin cannot interact with O-GlcNAc proteins in the extracellular milieu, because almost all these proteins are cytoplasmic. Nevertheless, apoptotic cells are predicted to release many O-GlcNAc-modified proteins as cellular debris. Therefore, we hypothesized that vimentin on the cell surface internalizes O-GlcNAc-modified proteins, which are released into the extracellular milieu from apoptotic cells. We further postulated that the GlcNAc-binding lectin-like properties of vimentin on the cell surface are involved in the clearance of O-GlcNAc-modified proteins. These hypotheses were demonstrated in vimentin-expressing common cell lines such as HeLa cells as in vitro experiments and on normal developmental clearance that occurs as the developing footplate is remodeled to transform webbed regions into free interdigital spaces. From these results, it is suggested that the physiological relevance involved in a GlcNAc-binding property of vimentin on cell surface is a common mechanism for the clearance of apoptotic cells by professional and nonprofessional phagocytes.
Results

Interaction of vimentin with O-GlcNAc-modified proteins from dying HeLa cells
First, we examined whether O-GlcNAc-modified proteins were expressed in ultraviolet C (UVC)-irradiated HeLa cervical carcinoma cells. Annexin V staining revealed that irradiation induced the apoptosis of HeLa cells within 4 h ( Figure 1A ). The degradation of vimentin is accompanied by the induction of apoptosis (Nakanishi et al. 2001) , and therefore, we examined its degradation following irradiation. We observed the marked degradation of vimentin at 4 and 24 h after irradiation (Supplementary data, Figure S1A ), and the induction of apoptosis was confirmed. Immunocytochemistry with anti-O-GlcNAc antibodies showed that O-GlcNAcmodified proteins were abundant in the cytoplasm of living, unirradiated cells; almost existed in the nucleus of irradiated cells immediately following irradiation (0 h); and were completely localized in the nucleus of irradiated cells cultured for more than 1 h ( Figure 1B and C) . Western blotting further indicated that the amount of O-GlcNAc-modified proteins in the cytoplasm decreased immediately following irradiation, while the amount of O-GlcNAc-modified proteins in the nucleus decreased gradually (Supplementary data, Figure S1B ). Furthermore, the total amount of O-GlcNAcmodified proteins in irradiated cells remained constant for 4 h, and then decreased after 24 h (Supplementary data, Figure S1C ).
These results indicate that O-GlcNAc-modified proteins were localized in the nucleus following the induction of cell death and that nuclear localization occurred at 1 h after irradiation. Moreover, to examine whether O-GlcNAc-modified proteins from apoptotic cells are recognized by surface vimentin of another living cells, we added a recombinant protein of the vimentin-rod II domain, the GlcNAc-binding domain, to UV-irradiated HeLa cells. It was observed that the rod II domain proteins interacted with O-GlcNAc-modified proteins in the nuclei of irradiated cells at 1, 2 and 4 h after irradiation ( Figure 1B and C) . The interaction of the vimentin-rod II domain with O-GlcNAc proteins was not inhibited by anti-O-GlcNAc antibodies (clone: RL2). Therefore, it was considered that the epitope of RL2 might be different from the binding site of the vimentin-rod II domain. These findings suggest that the surface vimentin of another living cell may interact with O-GlcNAc-modified proteins from apoptotic cells.
Interaction and engulfment of apoptotic cells by living cells
It has been reported that the engulfment of apoptotic cells is carried out by professional phagocytes such as macrophages and also by non-professional phagocytes such as mesenchymal cells. However, it remains to be determined whether common cell lines such as HeLa cells have the ability to engulf apoptotic cells. Thus, we examined whether irradiated HeLa cells were engulfed by living HeLa cells. To observe the engulfment of the irradiated HeLa cells by the living HeLa cells, the irradiated HeLa cells at 2 h after irradiation were cocultured with the living HeLa cells for 2 h. Using transmission electron microscopy, the interaction was observed. It was shown that the morphology of dying cells (UV-irradiated cells) was collapsed. Moreover, since living cells adhered on culture dishes, UV-irradiated cells were considered to be bound to living cells. Therefore, UV-irradiated cells could be distinguished from living cells. It was revealed that the irradiated cells (2 h) were attracted and bound to the living HeLa cells (Figure 2A-H) .
To elucidate the role of vimentin in this interaction, we added irradiated cells (2 h) that were labeled with 5-(N-succinimidyloxycarbonyl)-3′,6′-O,O′-diacetylfluorescein (CFSE; green fluorescence) to living HeLa cells that expressed DsRed protein-fused vimentin. Confocal laser scanning microscopy revealed that the irradiated cells (2 h) were internalized into the living HeLa cells and were surrounded by DsRed protein-fused vimentin at 16 and 24 h after coculturing the two types of cells ( Figure 2I and J). Moreover, time-lapse imaging until 20 h demonstrated that the living HeLa cells engulfed the irradiated cells ( Figure 2K , Supplementary data, Movie S1). These findings indicate that the living HeLa cells interacted with and internalized the irradiated cells. Thus, common cell lines such as HeLa cells have the ability to engulf apoptotic cells.
Clearance mechanism of apoptotic cells by surface vimentin
Role of the interaction of surface vimentin with O-GlcNAc-modified proteins in mediating the binding of irradiated cells to living HeLa cells We hypothesized that the internalization of apoptotic cells by living cells is mediated through the interaction of the O-GlcNAc-modified proteins from the apoptotic cells with surface vimentin on the living HeLa cells. We therefore performed an in situ proximity ligation assay (PLA) that can specifically detect complexes of O-GlcNAc-modified proteins and vimentin, using anti-O-GlcNAc and anti-vimentin-rod II antibodies. To only observe the interaction of the irradiated HeLa cells with the living HeLa cells, the irradiated HeLa cells at 0, 1, 2 and 4 h after irradiation were cocultured with the living HeLa cells for 1 h. Confocal laser scanning microscopy revealed that the irradiated cells (1, 2 and 4 h) interacted with the living HeLa cells, but not the irradiated cells Clearance mechanism of apoptotic cells by surface vimentin Figure 3A and D). Moreover, it was observed that the complexes detected by the in situ PLA were colocalized at the site of interaction of the irradiated cells with the living HeLa cells ( Figure 3A and B). The in situ PLA did not detect these complexes in unirradiated (living) or irradiated (apoptotic) cells alone ( Figure 3C , negative controls 1 and 2), indicating that vimentin did not interact with O-GlcNAc-modified proteins intracellularly. These results suggest that the interaction of living HeLa cells with the irradiated cells is mediated by the binding of surface vimentin on the living cells to O-GlcNAc-modified proteins from the irradiated cells. Furthermore, the nuclear localization of O-GlcNAc-modified proteins was not observed in irradiated cells immediately following irradiation (0 h, Figure 1B) , and the binding of these cells to the living HeLa cells was very low (Figure 3A and D). These findings suggest that the nuclear localization of O-GlcNAc-modified proteins in apoptotic cells is important for the interaction with surface vimentin on living cells. From the in situ PLA, it was observed that living HeLa cells could interact with the UV-irradiated cells through O-GlcNAc-modified proteins and surface vimentin. Therefore, when O-GlcNAc-modified proteins were nuclear localized in apoptotic cells, O-GlcNAc-modified proteins might be exposed to the cell surface.
Next, we examined whether the interaction is also performed in necrotic cells. Figure S2 ). These findings demonstrated that the interaction of freeze-thawed HeLa cells with living HeLa cells was performed similar to that of UV-irradiated HeLa cells (apoptotic cells) with living HeLa cells. It was assumed that O-GlcNAc-modified proteins in the freezethawed HeLa cells might be exposed to cell surface. Therefore, these results suggest that the clearance system of necrotic cells is also mediated by O-GlcNAc and surface vimentin.
The addition of GlcNAcylated polymers to cells phosphorylates vimentin (Ise et al. 2010 ). Thus, we also examined whether the interaction of O-GlcNAc-modified proteins with surface vimentin induced the phosphorylation of vimentin. We observed that Ser71 of vimentin was phosphorylated within 10 min of addition of irradiated cells (2 h) to living HeLa cells. In contrast, Ser38 was not phosphorylated ( Figure 3E ). These results further suggest that the dynamic regulation of vimentin in living cells is induced by the interaction of O-GlcNAc-modified proteins from apoptotic cells.
Role of O-GlcNAc-modified proteins from apoptotic cells in promoting the membrane recruitment of tetrameric vimentin
The addition of GlcNAcylated polymers to cells promotes the localization of vimentin on the cell surface (Ise et al. 2010) . Therefore, using cell surface biotinylation, we examined whether the addition of irradiated cells to living HeLa cells would have the same effect. It is necessary to avoid detecting vimentin from UV-irradiated cells for biotinylation of surface vimentin. Therefore, by using two different cell lines, namely, HeLa cells as living cells and Hepa 1-6 mouse hepatoma cells as irradiated (apoptotic cells) cells, we avoided detecting the vimentin from irradiated Hepa 1-6 cells and only immunoprecipitated the vimentin from living HeLa cells; indeed, mouse monoclonal anti-vimentin antibodies (V9) barely recognized mouse vimentin from Hepa 1-6 cells ( Figure 4A ). Hepa 1-6 cells were irradiated for 15 min and then were incubated for 2 h. Similar to the irradiated HeLa cells (2 h), the nuclear localization of O-GlcNAc-modified proteins was also observed in the irradiated Hepa 1-6 cells (Supplementary data, Figure S3A ). To only observe the interaction of the irradiated Hepa 1-6 cells with the living HeLa cells, the irradiated Hepa 1-6 cells at 2 h after irradiation were cocultured with living HeLa cells for 1 h. In the in situ PLA, the interaction with HeLa cells was also confirmed to be mediated by the O-GlcNAc-modified proteins and the surface vimentin (Supplementary data, Figure S3B ). The expression of biotinylated vimentin in living HeLa cells cocultured with irradiated Hepa 1-6 cells (2 h) was higher than that in living HeLa cells alone ( Figure 4B and D, rows 1 and 3). Moreover, using western blotting with anti-vimentin antibodies (V9), it was shown that a total amount of vimentin in each lysate was the same ( Figure 4C ). Vimentin can exist in cells as both a detergent-soluble form (disassembled vimentin) and a detergent-insoluble form (vimentin filaments) (Eriksson et al. 2004 ). Thus, we examined whether the biotinylated vimentin was disassembled or filamentous. Figure 4B (rows 3 and 4) shows that biotinylated vimentin was detected predominantly in the detergent-soluble lysate fraction and was therefore considered to be disassembled. These results suggest that O-GlcNAc-modified proteins from apoptotic cells promote the membrane recruitment of vimentin and the disassembly of vimentin filaments. To examine whether proteins from irradiated Hepa 1-6 cells interact with the surface vimentin of living HeLa cells, we biotinylated proteins from the irradiated Hepa 1-6 cells and added these to the living HeLa cells. We observed that many of the biotinylated proteins from the irradiated Hepa 1-6 cells coimmunoprecipitated with vimentin in the detergent-soluble fraction of the living HeLa cells ( Figure 4E ). Next, we examined whether the interaction of biotinylated proteins from Hepa 1-6 cells with the surface vimentin of living HeLa cells was decreased by a reduction in the O-GlcNAc modification level in the irradiated Hepa 1-6 cells. We tried to reduce the level of O-GlcNAc modification of UV-irradiated Hepa 1-6 cells using the incorporation of tetraacetylated N-azidoacetylglucosamine (GlcNAz) and knockdown of O-β-N-acetylglucosaminyltransferase (OGT) by small interfering RNA (siRNA)-OGT ( Figure 4F and G). The GlcNAz is incorporated into intracellular O-GlcNAccontaining glycoproteins through the permissive nature of the oligosaccharide biosynthesis pathway. It has been reported that GlcNAz could be incorporated into O-GlcNAc-modified proteins and other types of glycans (e.g. N-linked glycans), but GlcNAz is predominantly used to label the O-GlcNAcmodified proteins (Hart et al. 2011; Zaro et al. 2011) . The replacement of GlcNAc with GlcNAz was induced by the incorporation of GlcNAz, and the level of O-GlcNAc modification was shown to reduce by western blotting with anti-O-GlcNAc antibodies ( Figure 4F ). Moreover, the O-GlcNAz modification was confirmed by the detection of O-GlcNAzmodified proteins with Click-iT Biotin protein Analysis Detection Kit ( Figure 4F ). GlcNAz-incorporated O-GlcNAcmodified proteins (O-GlcNAz-modified proteins) are considered not to interact with vimentin because O-GlcNAz-modified proteins were not recognized by anti-O-GlcNAc antibodies. It was observed that the coimmunoprecipitation of the biotinylated proteins from the irradiated Hepa 1-6 cells was decreased ( Figure 4F ). Next, we tried to reduce the level of O-GlcNAc modification using the knockdown of OGT. OGT is known to regulate O-GlcNAc modification (Hart et al. 2007 ). The knockdown of OGT was performed using siRNA-OGT. It was shown that the levels of OGT and O-GlcNAc modification were reduced by siRNA-OGT ( Figure 4G ). It was observed that the coimmunoprecipitation of the biotinylated proteins from the irradiated Hepa 1-6 cells that were treated with siRNA-OGT was decreased ( Figure 4G ).
These results suggest that many of the proteins from apoptotic cells interact with surface vimentin on living cells. Vimentin phospho-Ser71 is involved in the disassembly of vimentin filaments (Eriksson et al. 2004 ). We therefore used blue native polyacrylamide gel electrophoresis (BN-PAGE) and western blot analysis to analyze the polymeric structure of vimentin in the detergent-soluble and detergent-insoluble lysate fractions. In the detergent-soluble fraction, we observed only tetrameric vimentin, whereas in the detergent-insoluble fraction, we observed tetrameric, hexameric, octameric and 16-meric vimentin ( Figure 4H ). Next, we employed ligand blot analysis using fluorescein isothiocyanate (FITC)-conjugated GlcNAc-bearing polymers (FITC-PV-GlcNAc) to examine whether the disassembled or filamentous vimentin possessed a GlcNAc-binding property. The proteins separated by BN-PAGE were assumed to retain the correct folding, and therefore, the GlcNAc-binding property of vimentin could be detected by the interaction with FITC-PV-GlcNAc. The applicability of ligand blot using FITC-PV-GlcNAc has previously been demonstrated (Ise et al. 2010) . In the present study, FITC-PV-GlcNAc detected only the tetrameric vimentin of the detergent-soluble fraction and not the vimentin of the detergent-insoluble fraction ( Figure 4I ). Since this tetrameric vimentin was not detected by FITC-conjugated glucosebearing polymers (FITC-PV-MA), it was considered that tetrameric vimentin interacted with FITC-PV-GlcNAc through GlcNAc specifically ( Figure 4I ). These results suggest that the tetrameric vimentin of the detergent-soluble fraction may have the structure for GlcNAc-binding activity, whereas the vimentin of the detergent-insoluble fraction may have a filamentous structure. Taken together, our findings indicate that surface vimentin has a tetrameric structure and a GlcNAc-binding property and can bind to O-GlcNAc-modified proteins from apoptotic cells. In contrast, vimentin filaments (higher-order multimers) are not localized on the cell surface and do not have a GlcNAc-binding property. Figure 5A, lane 2) . Therefore, we considered that the promotion of Ser71 phosphorylation was suppressed by treatment with HA-1077. To investigate the disassembly of vimentin by the inhibition of phosphorylation, we employed BN-PAGE to examine vimentin tetramers in the detergent-soluble (disassembled vimentin) and detergentinsoluble (filamentous vimentin) fractions. In comparison with control HeLa cells, the tetrameric vimentin in the detergentsoluble fraction of the HeLa cells treated with HA-1077 decreased, whereas that in the detergent-insoluble fraction increased ( Figure 5B ). Figure 5C shows that total amounts of vimentin in HeLa cells that were treated with and without HA-1077 were the same. These results demonstrate that the phosphorylation of vimentin Ser71 is suppressed by ROCK inhibition and that the disassembly of vimentin is suppressed by the inhibition of phosphorylation. We further observed that the surface recruitment of vimentin was induced by the addition of apoptotic cells ( Figure 4B ). Therefore, we examined whether the surface recruitment was reduced by the inhibition of phosphorylation and the suppression of disassembly. When Clearance mechanism of apoptotic cells by surface vimentin UV-irradiated Hepa 1-6 cells (2 h) as apoptotic cells were cocultured with living HeLa cells treated with HA-1077 for 60 min, the surface recruitment of vimentin decreased ( Figure 5D ). These results suggest that the surface recruitment of vimentin is carried out by disassembly of vimentin, accompanied by the phosphorylation of vimentin Ser71. Next, we examined whether the interaction of apoptotic cells was observed in HA-1077-treated HeLa cells. We revealed that UV-irradiated HeLa cells bound significantly less to HA-1077-treated HeLa cells than to HeLa cells (control; Figure 5E and negative-knockdown HeLa cells were produced by the transfection of vimentin-and negative-shRNA vectors. These shRNA-transfected cells expressed green fluorescent protein (GFP) and, therefore, irradiated HeLa cells were stained by Cyto-Red. Western blotting revealed that vimentin-knockdown HeLa cells expressed less vimentin than did negativeknockdown control cells ( Figure 6A ). In addition, the binding of irradiated cells (1 and 2 h; red) to living vimentinknockdown cells (green) was significantly lower than that to living negative-knockdown cells (green) (P = 6 × 10 −6 and P = 1 × 10 −6 , respectively). However, the difference in the irradiated cells (4 h) was no longer significant, because of incomplete vimentin knockdown ( Figure 6B and C) . These results suggest that O-GlcNAc-modified proteins from apoptotic cells are taken up by living cells via surface vimentin.
Next, we examined whether O-GlcNAc modification was required for the surface vimentin-mediated interaction between apoptotic and living cells. We tried to reduce the level of O-GlcNAc modification of UV-irradiated HeLa cells using the incorporation of GlcNAz, knockdown of OGT and trypsinization. Using western blotting with anti-O-GlcNAc antibodies, the level of O-GlcNAc modification was shown to reduce by the replacement of GlcNAc with GlcNAz ( Figure 6D ). Moreover, the O-GlcNAz modification was confirmed ( Figure 6D ). It was observed that the interaction of UV-irradiated HeLa cells that were treated with GlcNAz with living HeLa cells was reduced ( Figure 6E and F) . Next, we tried to reduce the level of O-GlcNAc modification using the knockdown of OGT. It was shown that the levels of OGT and O-GlcNAc modification were reduced by siRNA-OGT ( Figure 6G ). It was observed that the interaction of UV-irradiated HeLa cells that were treated with siRNA-OGT with living HeLa cells was reduced ( Figure 6H and I) . Moreover, we observed that O-GlcNAc modification of proteins in the irradiated HeLa cells (4 h) was completely eliminated by trypsinization for 5 min at 37°C ( Figure 6J ). We subsequently cocultured the HeLa cells trypsinyzed after irradiation (4 h) with living HeLa cells and observed that they barely interacted ( Figure 6K and L) .
These results demonstrated that O-GlcNAc modification is required for the interaction of apoptotic cells with living cells.
Role of the interaction of vimentin with O-GlcNAc-modified proteins in mediating the clearance of apoptotic footplate cells in mouse embryos
Next, we investigated whether the interaction between vimentin and O-GlcNAc-modified proteins plays a role in the clearance of apoptotic cells during the morphogenesis of embryonic tissues (such as the footplate in mouse embryos), which occurs between embryonic days E12.5 and E14.5 (Jacobson et al. 1997 ). At E12.5, the peripheral interdigital margins of some footplate cells exhibited terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining ( Figure 7A ), which indicates apoptosis, and also in situ PLA staining of vimentin and O-GlcNAc-modified proteins (Figure 7B-D) . By E13.5, apoptosis peaked and the interdigital webbing exhibited widespread TUNEL staining ( Figure 7E ), and also in situ PLA staining ( Figure 7F-I ). In the negative control, in situ PLA staining with anti-vimentin-rod II domain antibodies alone was not specific; however, there was a slight intrinsic fluorescence from invading hematopoietic cells in the interdigital webbing ( Figure 7I ). Furthermore, in the interdigital webbing regions stained by in situ PLA and TUNEL ( Figure 8H and I) , immunostaining for vimentin phospho-Ser71 and O-GlcNAc-modified proteins was colocalized ( Figure 8A-F) . High expression of vimentin was also observed in the interdigital webbing regions ( Figure 8G ). These results suggest that apoptotic interdigital cells are cleared by a mechanism that involves the uptake of O-GlcNAc proteins by surface vimentin on neighboring phagocytes. Although macrophages are thought to engulf and clear these apoptotic cells (Hopkinson-Woolley et al. 1994; Jacobson et al. 1997) , these macrophages are known to express vimentin (Mor-Vaknin et al. 2003) . Indeed, immunohistochemistry of F4/80 (a mouse macrophage-specific antigen) at E13.5 confirmed that many macrophages invaded the interdigital webbing ( Figure 9A-F) . Moreover, double staining with in situ PLA and F4/80 showed that vimentin from these macrophages interacted with O-GlcNAc-modified proteins in this region, although many cells other than macrophages were stained ( Figure 9E and F) . These results suggest that not only macrophages, but also other vimentin-expressing cells (such as mesenchymal cells), engulf and clear apoptotic footplate cells via the interaction between surface vimentin and O-GlcNAcmodified proteins.
Discussion
The results of our present study suggest a model for clearance of apoptotic cells by professional and non-professional phagocytes (Figure 10 apoptotic cells first bind the surface vimentin of neighboring phagocytes. The interaction with apoptotic cells promotes the phosphorylation of vimentin Ser71 with ROCK, which disassembles vimentin filaments and recruits tetramers to the cell surface. Here, the tetramers facilitate the engulfment and internalization of apoptotic cells. We have also demonstrated that only the tetramers in the detergent-soluble fraction (disassembled vimentin), and not those in the detergent-insoluble fraction (filamentous vimentin), possess a GlcNAc-binding property. We speculate that, in disassembled vimentin, the structure of the tetramers differs from that in filamentous vimentin. This model is consistent with a previous proteindocking simulation, which demonstrated that tetrameric vimentin could bind GlcNAcylated polymers (Ise et al. 2010) . In this study, mechanisms of the movement of the tetramers from the cytoplasm to the outside of the membrane remain to be clarified. Using western blotting analysis, it was demonstrated that the tetramers were in the soluble form, whereas filamentous vimentin not. Moreover, it has been reported that the vimentin-rod II domain may have high affinity for the lipid bilayer and include transmembrane domains (Ise et al. 2010) . From these findings, the tetramers that were degraded from vimentin filaments might be easy to move from the cytoplasm to the outside of membrane. We therefore predicted the interaction of intracellular vimentin with O-GlcNAcmodified proteins in living and apoptotic cells. However, we observed no interaction in the in situ PLA of dying and living HeLa cells alone, and also no GlcNAc-binding property of filamentous vimentin, suggesting that the interaction does not occur intracellularly. The existence of O-GlcNAc-modified vimentin has been reported (Ishihara et al. 2010) ; however, O-GlcNAc-modified proteins were not detected by in situ PLA. Taken together, these findings demonstrate that the in situ PLA detected the specific interaction of surface vimentin with O-GlcNAc-modified proteins from apoptotic cells. It is known that many O-GlcNAc proteins are multimerized intracellularly (Hart et al. 2007) . We considered that O-GlcNAcmodified proteins as debris that were released from apoptotic cells were multimerized and therefore could bind to surface vimentin. This is the first study to report that HeLa cells as Clearance mechanism of apoptotic cells by surface vimentin common cell lines engulf and clear apoptotic cells through the interaction of surface vimentin with O-GlcNAc-modified proteins. Nevertheless, we believe that our proposed model for the clearance of apoptotic cells is valid, because the immunostaining results of the in situ PLA are consistent with the surface recruitment of vimentin, and the coimmunoprecipitation of many proteins of apoptotic cells with vimentin. Furthermore, our results suggest that the model is involved in normal development, as indicated by the clearance of apoptotic footplate cells in mouse embryos at E13.5. This finding is consistent with the first appearance of vimentin in primitive mesoderm cells at E8.5 (Duprey and Paulin 1995) . Thus, our proposed model for the clearance of apoptotic cells may play an important role in developmental morphogenesis.
During the engulfment of apoptotic cells, apoptotic cells expose PtdSer on the cell surface, so that they can be recognized and engulfed by receptors on professional phagocytes (Nagata et al. 2010) . However, it is unclear whether the clearance mechanism of non-professional phagocytes also involves the recognition of PtdSer on apoptotic cells. In the present study, we observed annexin V staining of irradiated HeLa cells at 4 h after irradiation, which indicates the surface exposure of PtdSer. However, at 1 h after irradiation, the expression of O-GlcNAc-modified proteins was localized in the nuclei of irradiated HeLa cells. In addition, irradiated HeLa cells interacted with the living HeLa cells at least 1 h after irradiation, but prior to the surface exposure of PtdSer. The nuclear localization of O-GlcNAc-modified proteins in irradiated cells coincided with the interaction of irradiated and living cells and, therefore, may function as an "eat me" signal for engulfment via vimentin. Thus, our proposed model suggests that non-professional phagocytes clear apoptotic cells via a mechanism that acts before the recognition of PtdSer. The results of double staining with in situ PLA and F4/80 in the interdigital webbing at E13.5 support this mechanism of clearance. Thus, our model may be a general mechanism for the clearance of apoptotic cells by non-professional and also by professional phagocytes.
Vimentin plays a key role in our proposed model and is a member of the type III family of intermediate filaments, which also includes desmin, glial fibrillary acidic protein (GFAP) and peripherin. These proteins share the same GlcNAc-binding site in the C-terminal half of the rod II domain as vimentin. Desmin exhibits GlcNAc-binding activity on the cell surface of cardiomyocytes (Ise et al. 2010) , and therefore, it is likely that GFAP and peripherin have similar GlcNAc-binding activities on the surface of cells. The results of the present study suggest that the clearance of apoptotic cells may be a general function of type III intermediate filaments. Although single-gene knockout mice for each type III intermediate filament have been developed, their phenotypes are rather mild and they develop and reproduce normally (Colucci-Guyon et al. 1994; Galou et al. 1996; Li et al. 1997; Larivière et al. 2002) . The clearance of apoptotic cells is an essential physiological process. Since this process may be compensated by several type III intermediate filaments or other proteins, dysfunctions of these proteins as the phenotypes are assumed not to appear. In addition, dysregulation of the expression or function of these proteins may play a role in the pathogenesis of diseases that involve the clearance of apoptotic cells. In fact, it is known that the abnormal expression of type III intermediate filaments is implicated in malignant oncogenesis, autoimmune diseases and neurodegenerative diseases; however, their exact role is not known (Eriksson et al. 2009; Satelli and Li 2011) . Thus, further studies on the role of vimentin in the clearance of apoptotic cells may help to elucidate the molecular basis of a wide range of diseases. Moreover, these findings would be useful for the development of drug delivery systems for targeting diseases (Aso et al. 2007; Kobayashi et al. 2009; Kim et al. 2011) . Thus, our results may have important applications in the development and/or improvement of therapeutic strategies.
Materials and methods
Cell culture, UV irradiation, cell labeling and transfection HeLa and Hepa 1-6 cells (6.25 × 10 4 cells/cm 2 ) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum at 37°C in 5% CO 2 . After washing with phosphate-buffered saline (PBS), the cells were trypsinized with 0.25% trypsin/1 mM ethylenediaminetetraacetic acid (EDTA) solution for 5 min at 37°C. For UV irradiation, the growth medium was first changed to PBS, and the cells were then irradiated with UVC for 15 min. Afterwards, they were cultured for 4 h. Freeze-thawed HeLa cells as necrotic cells were prepared by freeze-thawing of HeLa cells. Next, the irradiated and freeze-thawed HeLa cells were harvested using scrapers and added to cultured HeLa cells. Before irradiation and freeze-thawing, HeLa cells were stained by incubating them with 20 µM CFSE or Cyto-Red (Dojindo Laboratories, Kumamoto, Japan) for 2 h at 37°C in 5% CO 2 . In the inhibition of ROCK, HeLa cells were treated with 100 µM HA-1077 (Enzo Life Sciences Inc., Farmingdale, NY) as a ROCK inhibiter, at 37°C in 5% CO 2 overnight. Fusion proteins between vimentin and DsRed-monomer fluorescent protein were produced by transfecting HeLa cells with pDsRed monomer Hyg-C1 rat vimentin (Clontech Laboratories Inc., Mountain View, CA) using the Neon ® Transfection System (Invitrogen, Carlsbad, CA).
Immunocytochemistry
To detect apoptosis, HeLa cells were incubated with Annexin V-Fluos (Roche Diagnosis GmbH, Mannheim, Germany), which was diluted 1:50 in Hank's balanced salt solution, for 15 min. Next, the cells were fixed in 4% paraformaldehyde (PFA)/PBS for 15 min, washed with 50 mM glycine/PBS and 
(C) Merged images of (A) and (B). (D) TUNEL staining. (E and F) Magnified images of (C).
Clearance mechanism of apoptotic cells by surface vimentin blocked with 10% goat serum in PBS for 15 min. Afterwards, to stain O-GlcNAc-modified proteins, the cells were incubated with mouse monoclonal anti-O-GlcNAc antibodies (1:100 dilution; clone RL2; Thermo, Rockford, IL) and 200 µg/mL of the recombinant His-tagged vimentin-rod II domain protein for 1 h at room temperature. Subsequently, the cells were incubated for 1 h with rabbit anti-His tag antibodies (1:200 dilution; Santa Cruz Biotechnology Inc., Santa Cruz, CA). Finally, the cells were incubated with CF488A goat antimouse IgG or CF555 donkey anti-rabbit IgG as secondary antibodies (1:1000 dilution; Biotium Inc., Hayward, CA) for 1 h at room temperature. The nucleus was stained with 0.1 µg/mL of 4′,6-diamidino-2-phenylindole (DAPI; Dojindo Laboratories).
The recombinant His-tagged vimentin-rod II domain protein was prepared as described previously (Ise et al. 2010) . Briefly, this protein was encoded by amino acids 328-411 of vimentin and was His 6 -tagged at the N terminus.
Immunohistochemistry
Pregnant ICR mice were purchased from Japan SLC Inc. (Shizuoka, Japan). All experiments were performed in accordance with the Tokyo Institute of Technology Guide for Laboratory Animals. After euthanizing the mice on days 12.5 and 13.5 of gestation, the embryos were isolated and their limbs were fixed with 4% PFA/PBS overnight at 4°C. Afterwards, these limbs were immersed in 20% sucrose/PBS overnight at 4°C. Next, the limbs were cryosectioned into 10-µm thick sections. These sections were fixed with 4% PFA/PBS for 15 min, washed with 50 mM glycine/PBS and blocked with 10% goat serum in PBS for 30 min. Subsequently, to block non-specific staining with endogenous mouse immunoglobulin, the sections were incubated with 100 µg/mL of goat anti-mouse IgG antibodies (Jackson ImmunoResearch Laboratories Inc., West Grove, PA), in 10% goat serum/PBS for 60 min at room temperature. Next, the sections were incubated with the rabbit anti-vimentin-rod II domain antiserum (1:100 dilution), mouse monoclonal anti-O-GlcNAc antibodies (1:100 dilution; Thermo) or rat monoclonal anti-phospho vimentin (Ser71) antibodies (1:100 dilution; Stressgen, Ann Arbor, MI) at 4°C overnight. The sections were incubated with CF488A goat anti-mouse IgG (1:1000 dilution; Biotium Inc.), CF555 donkey anti-rabbit IgG (1:1000 dilution; Biotium Inc.) or Alexa Fluor 546 goat anti-rat IgG (1:1000 dilution; Invitrogen) as secondary antibodies for 1 h at room temperature. The rabbit antivimentin-rod II domain antiserum can recognize surface vimentin, and its production was described previously (Ise et al. 2010) .
In situ PLA The in situ PLA was performed using the Duolink ® in situ PLA™ kit (Olink Bioscience, Uppsala, Sweden). Briefly, after fixing and blocking the living and irradiated cocultured cells, the cells were incubated with the rabbit anti-vimentin-rod II domain antiserum (1:100 dilution) and mouse monoclonal anti-O-GlcNAc antibodies (1:100 dilution) for 2 h at 37°C. For footplate sections from mouse embryos, the endogenous immunoglobulin was blocked, and the sections were incubated with the same concentration of antibodies at 4°C overnight. For the negative controls, the sections were incubated with the rabbit anti-vimentin-rod II domain antiserum alone. The in situ PLA-stained sections were incubated with 2 µg/mL of rat monoclonal anti-F4/80 antibodies (clone BM8; BMA Biomedicals, Augst, Switzerland), for 2 h at room temperature. Subsequently, the sections were incubated with CF488A donkey anti-rat IgG (1:1000 dilution; Biotium Inc.) as secondary antibodies, for 1 h at room temperature.
Confocal laser scanning microscopy
All the cells and sections were observed by confocal laser scanning microscopy (A1/A1R system; Nikon Instruments Inc., Tokyo, Japan) with a ×10/0.45 lens or a ×40/0.95 lens 
Establishment of vimentin-knockdown HeLa cells
Human vimentin-and negative-knockdown HeLa cells were established by transfecting cells with pcDNA™ 6.2-GW/ EmGFP-miR-human vimentin (vimentin-miRNA vector; Invitrogen) and pcDNA™ 6.2-GW/EmGFP-miR-neg control plasmid (negative-miRNA vector; Invitrogen), respectively. The vimentin-miRNA vector targeted the sequence CACACTTTCATATTGCTGACG (nucleotides 1230-1250 of human vimentin mRNA, GenBank Accession No. NM_003380). The negative-miRNA vector was not predicted to target any known vertebrate gene and contained an insert (GAAATGTACTGCGCGTGGAGACGTTTTGGCCACTGAC TGACGTCTCCACGCAGTACATTT) that could form a hairpin structure. Each of the vectors encoded GFP, and therefore, the miRNA-expressed cells expressed GFP synchronously. Stable cell lines that constitutively expressed these miRNAs and GFP were selected with blasticidin (Invitrogen).
Biotinylation of cell surface proteins or total cellular proteins The biotinylation was described previously (Ise et al. 2010) . Briefly, to biotinylate the surface proteins and total cellular proteins of HeLa and Hepa 1-6 cells, respectively, cultured cells were incubated with 100 µg/mL of sulfosuccinimidyl N-(D-biotinyl)-6-aminohexanoate (biotin-AC 5 -Sulfo-Osu; Dojindo Laboratories) in PBS at 4°C for 30 min. Biotin-AC 5 -Sulfo-Osu is water soluble and therefore cannot enter the cytoplasm. Thus, only the surface proteins of HeLa cells were biotinylated. However, the irradiated Hepa 1-6 cells were dying, and therefore, the integrity of their cell membranes was weak. Thus, the total cellular proteins were biotinylated. After the biotinylation reaction, the cells were incubated with DMEM for 5 min, to quench the unreacted biotin-AC 5 -SulfoOsu, and then washed three times with PBS.
Immunoprecipitation and western blot analysis Cells were lysed with a lysis buffer comprising 25 mM TrisHCl ( pH 7.5), 2.5 mM EDTA, 137 mM NaCl, 2.7 mM KCl, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate (SDS), 1% Nonidet P-40 (NP-40), 2 mM phenylmethylsulfonyl fluoride (PMSF) and a protease and phosphatase inhibitor cocktail (Nacalai Tesque, Kyoto, Japan), pH 7.5. The lysate was centrifuged at 20,000 × g for 30 min at 4°C, and the supernatants were collected. The nuclear and cytoplasmic proteins were extracted by using the NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo). These proteins were resolved on a 5-20% SDS-PAGE gradient gel (DRC Co. Ltd, Tokyo, Japan). After coculturing living HeLa cells with UV-irradiated Hepa 1-6 cells for 30 min, these cells were biotinylated and lysed in NP-40 lysis buffer comprising 150 mM aminocapronic acid, 1% NP-40, 50 mM Bis/Tris ( pH 7.0), 2 mM PMSF and a protease inhibitor cocktail (Nacalai Tesque), pH 7.0. For the coculture of living HeLa cells with biotinylated and UV-irradiated Hepa 1-6 cells for 1 h, the lysate was prepared in CHAPS lysis buffer comprising 500 mM aminocapronic acid, 1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS), 50 mM Bis/Tris ( pH 7.0), 2 mM PMSF and a protease inhibitor cocktail (Nacalai Tesque), pH 7.0.
The lysate was centrifuged at 20,000 × g for 30 min at 4°C. The supernatant (detergent-soluble fraction) and the pellet (detergent-insoluble fraction) were collected. Next, the pellets were dissolved in CHAPS lysis buffer and sonicated. The detergent-soluble and detergent-insoluble fractions were isolated and incubated with protein G magnetic beads (Millipore Corp., Billerica, MA), which were bound with mouse monoclonal antivimentin antibodies (V9; Sigma, St Louis, MO), for 1 h at 4°C.
After incubation, the proteins bound to these beads were resolved on a 10% SDS-PAGE gel (DRC Co. Ltd). Gel staining was performed using Oriole Fluorescent Gel stain (Bio-Rad Laboratories Inc., Hercules, CA). The proteins in the gel were electroblotted to a polyvinylidene fluoride (PVDF) membrane (Millipore Corp.). Western blot analysis was performed by incubation with horseradish peroxidase (HRP)-conjugated NeutrAvidin (1:5000 dilution; Thermo), V9 (1:10,000 dilution; Sigma), mouse monoclonal anti-β-actin antibodies (1:10,000 dilution; Sigma), rat monoclonal antiphospho vimentin (Ser71) antibodies (1:5000 dilution; Stressgen), rabbit monoclonal anti-phospho vimentin (Ser38) antibodies (1:5000 dilution; GeneTex Inc., Irvine, CA), anti-OGT antibodies (1:2000 dilution; GeneTex Inc.) or anti-O-GlcNAc antibodies (1:1000 dilution; Covance, Emeryville, CA). Ligand blotting was performed by incubation with FITC-PV-GlcNAc and FITC-PV-MA (1:1000 dilution; Celagix Res Ltd, Yokohama, Japan) and then with goat anti-FITC antibodies (1:2500 dilution; Bethyl Laboratoris, Inc., Montgomery, TX). Subsequently, the PVDF membrane was incubated with HRP-conjugated anti-rat IgG, rabbit IgG, mouse IgG, goat IgG or mouse IgM antibodies (1:20,000 dilution; Jackson ImmunoResearch Laboratories, Inc.) as secondary antibodies. Densitometric analysis was performed using Image J (version 1.38X; National Institutes of Health).
Reduction of O-GlcNAc-modification levels in UV-irradiated HeLa cells and Hepa 1-6 cells
The reduction in O-GlcNAc modification levels was performed by the incorporation of GlcNAz and the knockdown of OGT. In the incorporation of GlcNAz into O-GlcNAc-modified proteins, before irradiation, cells were incubated with 100 µM GlcNAz for 72 h. O-GlcNAz-modified proteins were detected by Click-iT Biotin protein Analysis Detection Kit (Invitrogen) under the manufacturer's instructions. The biotinylation of O-GlcNAz-modified proteins was detected by western blotting with HRP-NeutrAvidin. The knockdown of OGT was performed by the transfection of OGT siRNAs (final concentration, 100 nM). The transfection was performed by Lipofectamine RNAiMAX (Invitrogen) according to the Clearance mechanism of apoptotic cells by surface vimentin manufacturer's instructions. The human and mouse OGT and negative control siRNAs were purchased as Stealth RNAi siRNA Duplex Oligoribonucleotides (Invitrogen). The targeting sequences of the human and mouse OGT siRNAs were shown as follows (nucleotides 924-948 of human OGT, GenBank Accession No. U77413, sense: 5′-CAGUUCGCUU GUAUCGUAAAGCAUU-3′, antisense: 5′-AAUGCUUUAC GAUACAAGCGAACUG-3′; nucleotides 749-773 of mouse OGT, GenBank Accession No. NM_139144, sense: 5′-CCA AGGCAUGUUAUUUGAAAGCAU-3′, antisense: 5′-AUUG CUUUCAAAUAACAUGCCUUGG-3′), and sequences of the negative control siRNA were shown as follows (sense: 5′-CC AUACGAUUGGUUUGAAACGAAAU-3′, antisense: 5′-AU UUCGUUUCAAACCAAUCGUAUGG-3′).
Blue native PAGE BN-PAGE was performed according to the method of Valentijn et al. (2008) . Briefly, the detergent-soluble and detergent-insoluble fractions were dissolved in a loading buffer comprising 0.5% Coomassie Brilliant Blue (CBB) G-250, 50 mM aminocapronic acid, 10 mM Bis/Tris ( pH 7.0) and 10% glycerol and then incubated for 30 min at 4°C. Subsequently, these solutions were resolved on a 5-20% gradient gel, which was electrophoresed at 150 V for 1 h at room temperature using the DRC BN-PAGE system. The gel was stained using CBB Stain One (Nacalai Tesque). Western blotting and ligand blotting were performed according to "Materials and methods, Immunoprecipitation and western blot analysis".
Time-lapse imaging
Time-lapse imaging was performed using a Biostation IM (Nikon Instruments Inc.) live cell imaging system. CFSE-labeled, UV-irradiated HeLa cells were cocultured with living cells that expressed DsRed-monomer-vimentin fusion proteins. The cells were photographed every 30 min for 20 h.
Transmission electron microscopy
Transmission electron microscopy was performed by Tokai Electron Microscopy (Nagoya, Japan). UV-irradiated HeLa cells were cocultured with HeLa cells on 35 mm dishes for 2 h. Two hours later, the cells were fixed with 2% PFA and glutaraldehyde/PBS and analyzed by transmission electron microscopy.
Statistical analyses
All data are expressed as the mean (SD) of at least three independent experiments. Statistically significant differences between two groups were determined using an unpaired Student's t-test. A P-value of <0.01 was considered statistically significant.
Supplementary data
Supplementary data for this article is available online at http://glycob.oxfordjournals.org/.
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